Goreisan Prophylactic Postoperative nausea and vomitting Prevention Trial

Goreisan Prophylactic Postoperative nausea and vomitting Prevention Trial - gpppt

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220060

Enrollment

100

Registered

2011-06-01

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

Intervention type:DRUG Name of intervention:Goreisan Dose form / Japanese Medical Device Nomenclature:POWDER Route of administration / Site of application:ORAL Dose per administration:2.5 7.5 g Dosing

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: over 18 years old female benign gynecological disease laparoscopic surgery

Exclusion criteria

Exclusion criteria: have gastrointestinal disease take anti-emetic drug take kampo medicine take opioid be pregnant be under breast-feeding

Design outcomes

Primary

Measure	Time frame
prevention effect of postoperative nausea and vomiting	—

Secondary

Measure	Time frame
prevention effect of postoperative nausea and vomiting	—

Countries

Japan

Contacts

Public ContactKORI kazuyoshi

Osaka Medical College

korikazuyoshi@gmail.com+81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026